Skip to content

Drug: Cannabidiol: chronic pain clinical trials

Registry records that list "Drug: Cannabidiol" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
9
Registry records in total

Trials in Canada

No trial with a Canadian site lists this intervention in this snapshot.

Trials worldwide (outside Canada)

9 trials, 2 recruiting or not yet recruiting. Recruiting first.

PhaseCountries
Cannabidiol in Sickle Cell Disease
NCT06930703
RecruitingPhase 1, Phase 2United StatesIcahn School of Medicine at Mount Sinai2025-04-03
MIVetsCan: Cannabidiol (CBD)-Care Trial
NCT06213233
RecruitingPhase 2United StatesKevin Boehnke2024-02-12
PAIN: A Project Assessing the Impact of a Novel Cannabinoid Product
NCT03984565
Active, not recruitingPhase 2United StatesStaci Gruber, Ph.D.2024-06-27
Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.
NCT05002114
WithdrawnPhase 1Louisiana State University Health Sciences Center Shreveport2023-01
CBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT)
NCT04760613
CompletedPhase 1, Phase 2United StatesNYU Langone Health2022-02-03
Cannabidiol for Fibromyalgia (The CANNFIB Trial)
NCT04729179
CompletedPhase 3DenmarkMarius Henriksen2021-03-01
Mechanisms of CBD for Chronic Pain
NCT04044729
CompletedEarly phase 1United StatesUniversity of Utah2020-03-16
Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
NCT03891264
TerminatedPhase 4United StatesMassachusetts General Hospital2019-11-13
Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)
NCT03215940
CompletedEarly phase 1United StatesUniversity of Utah2018-02-01

Conditions studied with this intervention

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.